Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Aug;65(2):483–492. doi: 10.1086/302494

A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.

G Zhu 1, D L Duffy 1, A Eldridge 1, M Grace 1, C Mayne 1, L O'Gorman 1, J F Aitken 1, M C Neale 1, N K Hayward 1, A C Green 1, N G Martin 1
PMCID: PMC1377947  PMID: 10417291

Abstract

Important risk factors for melanoma are densely clustered melanocytic nevi (common moles) and mutations in the p16 (CDKN2A) gene. Nevi may be subclassified as raised or flat. In our sample, raised nevi were 27% of the total, and the two kinds had a correlation of.33. Correlations for total-nevus count (TNC) in 153 MZ and 199 DZ twin pairs were.94 and.60, respectively, which are compatible with a very-high degree of genetic determination. We hypothesized that some of the genetic variance might be due to variation in the p16 gene. Analysis of linkage to a highly polymorphic marker (D9S942), located close to p16, detected quantitative-trait-loci (QTL) effects accounting for 27% of variance in TNC, rising to 33% if flat but not raised moles were considered. Total heritability was higher for raised (.69) than for flat (.42) moles, but QTL linkage was 0 for raised moles, whereas it accounted for 80% of the heritability of flat moles; additionally, family environment accounted for only 15% of variance in raised versus 46% in flat moles. These findings suggest that raised and flat nevi have very different etiologies. Longer alleles at D9S942 were associated with higher flat-mole counts, and a novel modification to a within-sibship association test showed that this association is genuine and not due to population stratification, although it accounts for only 1% of total variance. Since germline mutations in the exons of CDKN2A are rare, it is likely that variants in the noncoding regions of this gene, or in another gene nearby, are responsible for this major determinant of moliness and, hence, of melanoma risk.

Full Text

The Full Text of this article is available as a PDF (280.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken J. F., Green A., Eldridge A., Green L., Pfitzner J., Battistutta D., Martin N. G. Comparability of naevus counts between and within examiners, and comparison with computer image analysis. Br J Cancer. 1994 Mar;69(3):487–491. doi: 10.1038/bjc.1994.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aitken J., Welch J., Duffy D., Milligan A., Green A., Martin N., Hayward N. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst. 1999 Mar 3;91(5):446–452. doi: 10.1093/jnci/91.5.446. [DOI] [PubMed] [Google Scholar]
  3. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998 May;62(5):1198–1211. doi: 10.1086/301844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Amos C. I. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994 Mar;54(3):535–543. [PMC free article] [PubMed] [Google Scholar]
  5. Boomsma D. I. Using multivariate genetic modeling to detect pleiotropic quantitative trait loci. Behav Genet. 1996 Mar;26(2):161–166. doi: 10.1007/BF02359893. [DOI] [PubMed] [Google Scholar]
  6. Briollais L., Chompret A., Guilloud-Bataille M., Feingold N., Avril M. F., Demenais F. Genetic and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of nevi. Genet Epidemiol. 1996;13(4):385–402. doi: 10.1002/(SICI)1098-2272(1996)13:4<385::AID-GEPI7>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  7. Cannon-Albright L. A., Meyer L. J., Goldgar D. E., Lewis C. M., McWhorter W. P., Jost M., Harrison D., Anderson D. E., Zone J. J., Skolnick M. H. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res. 1994 Dec 1;54(23):6041–6044. [PubMed] [Google Scholar]
  8. Duffy D. L., Macdonald A. M., Easton D. F., Ponder B. A., Martin N. G. Is the genetics of moliness simply the genetics of sun exposure? A path analysis of nevus counts and risk factors in British twins. Cytogenet Cell Genet. 1992;59(2-3):194–196. doi: 10.1159/000133243. [DOI] [PubMed] [Google Scholar]
  9. Easton D. F., Cox G. M., Macdonald A. M., Ponder B. A. Genetic susceptibility to naevi--a twin study. Br J Cancer. 1991 Dec;64(6):1164–1167. doi: 10.1038/bjc.1991.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eaves L. J., Neale M. C., Maes H. Multivariate multipoint linkage analysis of quantitative trait loci. Behav Genet. 1996 Sep;26(5):519–525. doi: 10.1007/BF02359757. [DOI] [PubMed] [Google Scholar]
  11. Fulker D. W., Cherny S. S. An improved multipoint sib-pair analysis of quantitative traits. Behav Genet. 1996 Sep;26(5):527–532. doi: 10.1007/BF02359758. [DOI] [PubMed] [Google Scholar]
  12. Fulker D. W., Cherny S. S., Sham P. C., Hewitt J. K. Combined linkage and association sib-pair analysis for quantitative traits. Am J Hum Genet. 1999 Jan;64(1):259–267. doi: 10.1086/302193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldgar D. E., Cannon-Albright L. A., Meyer L. J., Piepkorn M. W., Zone J. J., Skolnick M. H. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst. 1991 Dec 4;83(23):1726–1733. doi: 10.1093/jnci/83.23.1726. [DOI] [PubMed] [Google Scholar]
  14. Green A., Siskind V., Green L. The incidence of melanocytic naevi in adolescent children in Queensland, Australia. Melanoma Res. 1995 Jun;5(3):155–160. doi: 10.1097/00008390-199506000-00003. [DOI] [PubMed] [Google Scholar]
  15. Green A., Swerdlow A. J. Epidemiology of melanocytic nevi. Epidemiol Rev. 1989;11:204–221. doi: 10.1093/oxfordjournals.epirev.a036037. [DOI] [PubMed] [Google Scholar]
  16. Gruis N. A., Sandkuijl L. A., van der Velden P. A., Bergman W., Frants R. R. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res. 1995 Jun;5(3):169–177. doi: 10.1097/00008390-199506000-00005. [DOI] [PubMed] [Google Scholar]
  17. Harrison S. L., MacLennan R., Speare R., Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet. 1994 Dec 3;344(8936):1529–1532. doi: 10.1016/s0140-6736(94)90348-4. [DOI] [PubMed] [Google Scholar]
  18. Holland E. A., Beaton S. C., Becker T. M., Grulet O. M., Peters B. A., Rizos H., Kefford R. F., Mann G. J. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene. 1995 Dec 7;11(11):2289–2294. [PubMed] [Google Scholar]
  19. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., 3rd, Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994 Apr 15;264(5157):436–440. doi: 10.1126/science.8153634. [DOI] [PubMed] [Google Scholar]
  20. Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N. A., Ding W., Hussey C., Tran T., Miki Y., Weaver-Feldhaus J. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 1994 Sep;8(1):23–26. doi: 10.1038/ng0994-22. [DOI] [PubMed] [Google Scholar]
  21. Kelly J. W., Rivers J. K., MacLennan R., Harrison S., Lewis A. E., Tate B. J. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 1994 Jan;30(1):40–48. doi: 10.1016/s0190-9622(94)70005-2. [DOI] [PubMed] [Google Scholar]
  22. Kruglyak L., Lander E. S. High-resolution genetic mapping of complex traits. Am J Hum Genet. 1995 May;56(5):1212–1223. [PMC free article] [PubMed] [Google Scholar]
  23. Lange K., Westlake J., Spence M. A. Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet. 1976 May;39(4):485–491. doi: 10.1111/j.1469-1809.1976.tb00156.x. [DOI] [PubMed] [Google Scholar]
  24. MacLennan R., Green A. C., McLeod G. R., Martin N. G. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992 Sep 16;84(18):1427–1432. doi: 10.1093/jnci/84.18.1427. [DOI] [PubMed] [Google Scholar]
  25. Martin N. G., Clark P., Ofulue A. F., Eaves L. J., Corey L. A., Nance W. E. Does the PI polymorphism alone control alpha-1-antitrypsin expression? Am J Hum Genet. 1987 Mar;40(3):267–277. [PMC free article] [PubMed] [Google Scholar]
  26. Martin N. G., Eaves L. J. The genetical analysis of covariance structure. Heredity (Edinb) 1977 Feb;38(1):79–95. doi: 10.1038/hdy.1977.9. [DOI] [PubMed] [Google Scholar]
  27. Martin N., Boomsma D., Machin G. A twin-pronged attack on complex traits. Nat Genet. 1997 Dec;17(4):387–392. doi: 10.1038/ng1297-387. [DOI] [PubMed] [Google Scholar]
  28. McGregor B., Pfitzner J., Zhu G., Grace M., Eldridge A., Pearson J., Mayne C., Aitken J. F., Green A. C., Martin N. G. Genetic and environmental contributions to size, color, shape, and other characteristics of melanocytic naevi in a sample of adolescent twins. Genet Epidemiol. 1999;16(1):40–53. doi: 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  29. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Milán T., Kaprio J., Verkasalo P. K., Jansén C. T., Teppo L., Koskenvuo M. Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins. Br J Cancer. 1998 Dec;78(11):1516–1520. doi: 10.1038/bjc.1998.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ohta M., Nagai H., Shimizu M., Rasio D., Berd D., Mastrangelo M., Singh A. D., Shields J. A., Shields C. L., Croce C. M. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res. 1994 Oct 15;54(20):5269–5272. [PubMed] [Google Scholar]
  32. Platz A., Hansson J., Månsson-Brahme E., Lagerlof B., Linder S., Lundqvist E., Sevigny P., Inganäs M., Ringborg U. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J Natl Cancer Inst. 1997 May 21;89(10):697–702. doi: 10.1093/jnci/89.10.697. [DOI] [PubMed] [Google Scholar]
  33. Pollock P. M., Pearson J. V., Hayward N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer. 1996 Feb;15(2):77–88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  34. Ranade K., Hussussian C. J., Sikorski R. S., Varmus H. E., Goldstein A. M., Tucker M. A., Serrano M., Hannon G. J., Beach D., Dracopoli N. C. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet. 1995 May;10(1):114–116. doi: 10.1038/ng0595-114. [DOI] [PubMed] [Google Scholar]
  35. Reymond A., Brent R. p16 proteins from melanoma-prone families are deficient in binding to Cdk4. Oncogene. 1995 Sep 21;11(6):1173–1178. [PubMed] [Google Scholar]
  36. Schmoeckel C. Classification of melanocytic nevi: do nodular and flat nevi develop differently? Am J Dermatopathol. 1997 Feb;19(1):31–34. doi: 10.1097/00000372-199702000-00006. [DOI] [PubMed] [Google Scholar]
  37. Soufir N., Avril M. F., Chompret A., Demenais F., Bombled J., Spatz A., Stoppa-Lyonnet D., Bénard J., Bressac-de Paillerets B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet. 1998 Feb;7(2):209–216. doi: 10.1093/hmg/7.2.209. [DOI] [PubMed] [Google Scholar]
  38. Swerdlow A. J., Green A. Melanocytic naevi and melanoma: an epidemiological perspective. Br J Dermatol. 1987 Aug;117(2):137–146. doi: 10.1111/j.1365-2133.1987.tb04109.x. [DOI] [PubMed] [Google Scholar]
  39. Worret W. I., Burgdorf W. H. Which direction do nevus cells move? Abtropfung reexamined. Am J Dermatopathol. 1998 Apr;20(2):135–139. doi: 10.1097/00000372-199804000-00005. [DOI] [PubMed] [Google Scholar]
  40. Zuo L., Weger J., Yang Q., Goldstein A. M., Tucker M. A., Walker G. J., Hayward N., Dracopoli N. C. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet. 1996 Jan;12(1):97–99. doi: 10.1038/ng0196-97. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES